Literature DB >> 21516351

Effects of a brain-engraftable microglial cell line expressing anti-prion scFv antibodies on survival times of mice infected with scrapie prions.

Koji Fujita1, Yoshitaka Yamaguchi, Tsuyoshi Mori, Naomi Muramatsu, Takahito Miyamoto, Masashi Yano, Hironori Miyata, Akira Ootsuyama, Makoto Sawada, Haruo Matsuda, Ryuji Kaji, Suehiro Sakaguchi.   

Abstract

We first verified that a single chain Fv fragment against prion protein (anti-PrP scFv) was secreted by HEK293T cells and prevented prion replication in infected cells. We then stably expressed anti-PrP scFv in brain-engraftable murine microglial cells and intracerebrally injected these cells into mice before or after infection with prions. Interestingly, the injection before or at an early time point after infection attenuated the infection marginally but significantly prolonged survival times of the mice. These suggest that the ex vivo gene transfer of anti-PrP scFvs using brain-engraftable cells could be a possible immunotherapeutic approach against prion diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21516351     DOI: 10.1007/s10571-011-9696-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  23 in total

1.  Prions prevent neuronal cell-line death.

Authors:  C Kuwahara; A M Takeuchi; T Nishimura; K Haraguchi; A Kubosaki; Y Matsumoto; K Saeki; Y Matsumoto; T Yokoyama; S Itohara; T Onodera
Journal:  Nature       Date:  1999-07-15       Impact factor: 49.962

2.  Prion strain-dependent differences in conversion of mutant prion proteins in cell culture.

Authors:  Ryuichiro Atarashi; Valerie L Sim; Noriyuki Nishida; Byron Caughey; Shigeru Katamine
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Brain-specific gene expression by immortalized microglial cell-mediated gene transfer in the mammalian brain.

Authors:  M Sawada; F Imai; H Suzuki; M Hayakawa; T Kanno; T Nagatsu
Journal:  FEBS Lett       Date:  1998-08-14       Impact factor: 4.124

4.  Differentiated regulation of allo-antigen presentation by different types of murine microglial cell lines.

Authors:  T Kanzawa; M Sawada; K Kato; K Yamamoto; H Mori; R Tanaka
Journal:  J Neurosci Res       Date:  2000-11-01       Impact factor: 4.164

5.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

6.  Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice.

Authors:  Chang-Hyun Song; Hidefumi Furuoka; Chan-Lan Kim; Michiko Ogino; Akio Suzuki; Rie Hasebe; Motohiro Horiuchi
Journal:  J Gen Virol       Date:  2008-06       Impact factor: 3.891

Review 7.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  CNS delivery of vectored prion-specific single-chain antibodies delays disease onset.

Authors:  Charles A Wuertzer; Mark A Sullivan; Xing Qiu; Howard J Federoff
Journal:  Mol Ther       Date:  2008-01-08       Impact factor: 11.454

9.  Toxic effects of intracerebral PrP antibody administration during the course of BSE infection in mice.

Authors:  Maxime Lefebvre-Roque; Elisabeth Kremmer; Sabine Gilch; Wen-Quan Zou; Cécile Féraudet; Chantal Mourton Gilles; Nicole Salès; Jacques Grassi; Pierluigi Gambetti; Thierry Baron; Hermann Schätzl; Corinne Ida Lasmézas
Journal:  Prion       Date:  2007-07-15       Impact factor: 3.931

10.  Development of antibody fragments for immunotherapy of prion diseases.

Authors:  Vincenza Campana; Lorena Zentilin; Ilaria Mirabile; Agata Kranjc; Philippe Casanova; Mauro Giacca; Stanley B Prusiner; Giuseppe Legname; Chiara Zurzolo
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

View more
  12 in total

Review 1.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

2.  Prions disturb post-Golgi trafficking of membrane proteins.

Authors:  Keiji Uchiyama; Naomi Muramatsu; Masashi Yano; Takeshi Usui; Hironori Miyata; Suehiro Sakaguchi
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

3.  Neurotropic influenza A virus infection causes prion protein misfolding into infectious prions in neuroblastoma cells.

Authors:  Hideyuki Hara; Junji Chida; Keiji Uchiyama; Agriani Dini Pasiana; Etsuhisa Takahashi; Hiroshi Kido; Suehiro Sakaguchi
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

Review 4.  Gene-based antibody strategies for prion diseases.

Authors:  Alessio Cardinale; Silvia Biocca
Journal:  Int J Cell Biol       Date:  2013-08-21

Review 5.  Prion protein-specific antibodies-development, modes of action and therapeutics application.

Authors:  Tihana Lenac Rovis; Giuseppe Legname
Journal:  Viruses       Date:  2014-10-01       Impact factor: 5.048

Review 6.  Neuroinflammation in Prion Disease.

Authors:  Bei Li; Meiling Chen; Caihong Zhu
Journal:  Int J Mol Sci       Date:  2021-02-23       Impact factor: 5.923

Review 7.  Antibody Fragments as Tools for Elucidating Structure-Toxicity Relationships and for Diagnostic/Therapeutic Targeting of Neurotoxic Amyloid Oligomers.

Authors:  André L B Bitencourt; Raquel M Campos; Erika N Cline; William L Klein; Adriano Sebollela
Journal:  Int J Mol Sci       Date:  2020-11-24       Impact factor: 5.923

8.  Biological and biochemical characterization of mice expressing prion protein devoid of the octapeptide repeat region after infection with prions.

Authors:  Yoshitaka Yamaguchi; Hironori Miyata; Keiji Uchiyama; Akira Ootsuyama; Sachiko Inubushi; Tsuyoshi Mori; Naomi Muramatsu; Shigeru Katamine; Suehiro Sakaguchi
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

Review 9.  Single-chain fragment variable passive immunotherapies for neurodegenerative diseases.

Authors:  Liang Huang; Xiaomin Su; Howard J Federoff
Journal:  Int J Mol Sci       Date:  2013-09-17       Impact factor: 5.923

Review 10.  Recombinant Antibody Fragments for Neurodegenerative Diseases.

Authors:  Karen Manoutcharian; Roxanna Perez-Garmendia; Goar Gevorkian
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.